Tianjin Chase Sun Pharmaceutical News and Activities

Tianjin Chase Sun Pharmaceutical is a company listed under the stock ticker 300026 (CN).

View the org chart displaying its 15 main executives

Most searched biographies at Tianjin Chase Sun Pharmaceutical

• Wujun Lan, Vice Chairman of the Board and General Manager
• Wu Sun, Director
• Juan Chen, Director

Create your alert
to follow the executive moves at Tianjin Chase Sun Pharmaceutical.

Tianjin Chase Sun Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Tianjin Chase Sun Pharmaceutical

Social media about Tianjin Chase Sun Pharmaceutical

• Tianjin Chase Sun Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Chase Sun Pharmaceutical on LinkedIn, X (Twitter) & YouTube